Show simple item record

dc.contributor.authorOffice of Marketing and Communications. Media Relations
dc.date.accessioned2018-02-05T18:43:26Z
dc.date.available2018-02-05T18:43:26Z
dc.date.issued2018-01-09
dc.identifier.urihttps://hdl.handle.net/1813/55766
dc.description.abstractThis news item from the Cornell Chronicle is about: Cornell researchers are investigating compounds they identified that offer hope for effective new drugs against tuberculosis. “Tuberculosis now kills more people than HIV every year. It’s the leading infectious disease on the planet in terms of human death,” said Brian VanderVen, assistant professor of microbiology and immunology in the College of Veterinary Medicine, and principal investigator of a new five-year, $2.5 million National Institutes of Health grant to study new compounds that he and colleagues identified and described. “We need new anti-tuberculosis antibiotics that work better and faster.”
dc.language.isoen_US
dc.publisherCornell University, College of Veterinary Medicine
dc.subjectCornell University. College of Veterinary Medicine -- Periodicals.
dc.subjectVanderVen, Brian
dc.subjectCornell Chronicle
dc.subjectRamanujan, Krishna
dc.title2018 CVM News: $2.5M grant funds research on tuberculosis treatment
dc.typearticle


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Statistics